rs79833450
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PP3_ModeratePP5_Very_Strong
The NM_012144.4(DNAI1):c.1543G>A(p.Gly515Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,614,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. G515G) has been classified as Likely benign.
Frequency
Consequence
NM_012144.4 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAI1 | NM_012144.4 | c.1543G>A | p.Gly515Ser | missense_variant | Exon 16 of 20 | ENST00000242317.9 | NP_036276.1 | |
| DNAI1 | NM_001281428.2 | c.1555G>A | p.Gly519Ser | missense_variant | Exon 16 of 20 | NP_001268357.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152152Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251492 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461870Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74324 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:3
- -
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 515 of the DNAI1 protein (p.Gly515Ser). This variant is present in population databases (rs79833450, gnomAD 0.009%). This missense change has been observed in individual(s) with clinical features of primary ciliary dyskinesia (PMID: 11231901, 21143860, 30868567; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 5606). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DNAI1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
The p.G515S pathogenic mutation (also known as c.1543G>A), located in coding exon 16 of the DNAI1 gene, results from a G to A substitution at nucleotide position 1543. The glycine at codon 515 is replaced by serine. This pathogenic mutation was first described in two siblings with recurrent respiratory infections, immotile spermatozoa, and one sibling was confirmed to have absent or truncated outer dynein arms on electron microscopy; both siblings also carried the c.48+2dupT pathogenic mutation in trans (Guichard C et al. Am J Hum Genet. 2001;68(4):1030-5). This pathogenic mutation has also been described in a patient, who also carried the c.48+2dupT pathogenic mutation, with recurrent respiratory infetions, situs inversus, nasal polyps, but no outer dynein defects on electron microscopy; however, ex vivo cultures of the patient's epithelial airway found his cilia were immotile (Chhin B et al. PLoS Genet. 2009;5(3):e1000422). Based on the supporting evidence, p.G515S is interpreted as a disease-causing mutation. -
Kartagener syndrome Pathogenic:3
- -
- -
- -
DNAI1-related disorder Pathogenic:1
The DNAI1 c.1543G>A variant is predicted to result in the amino acid substitution p.Gly515Ser. This variant has been reported in the compound heterozygous state with a second DNAI1 variant in individuals with Kartagener syndrome or primary ciliary dyskinesia (Guichard et al 2001. PubMed ID: 11231901; Chhin B et al 2009. PubMed ID: 19300481; Ziętkiewicz E et al 2010. PubMed ID: 21143860; Westphal DS et al 2019. PubMed ID: 30868567). This variant is reported in 0.0087% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-34513163-G-A). This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at